CD8A and infection: During primary infection with VACV, deletion of N1 or a I6E mutation resulted in enhanced CD8+ T-cell (but not CD4+ or NK) cytotoxicity, increased numbers of CD8+ (but not CD4+) TCM and TEM cells, and better protection against challenge with VACV.